Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group

for the MRI working group of the IPSCSG

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra- and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards, and its potential as a research tool is lacking. Conclusion: Members of the International PSC Study Group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards, and future areas of research. (Hepatology 2017;66:1675–1688).

Original languageEnglish (US)
Pages (from-to)1675-1688
Number of pages14
JournalHepatology
Volume66
Issue number5
DOIs
StatePublished - Nov 1 2017

Fingerprint

Sclerosing Cholangitis
Magnetic Resonance Imaging
Technology
Extrahepatic Bile Ducts
Gastroenterology
North America
Research
Fibrosis
Inflammation
Liver

ASJC Scopus subject areas

  • Hepatology

Cite this

Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. / for the MRI working group of the IPSCSG.

In: Hepatology, Vol. 66, No. 5, 01.11.2017, p. 1675-1688.

Research output: Contribution to journalReview article

@article{dac7c8c94fa34a08ad7bfad1e9ae7ba2,
title = "Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra- and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards, and its potential as a research tool is lacking. Conclusion: Members of the International PSC Study Group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards, and future areas of research. (Hepatology 2017;66:1675–1688).",
author = "{for the MRI working group of the IPSCSG} and Christoph Schramm and John Eaton and Ringe, {Kristina I.} and Venkatesh, {Sudhakar K} and Jin Yamamura",
year = "2017",
month = "11",
day = "1",
doi = "10.1002/hep.29293",
language = "English (US)",
volume = "66",
pages = "1675--1688",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group

AU - for the MRI working group of the IPSCSG

AU - Schramm, Christoph

AU - Eaton, John

AU - Ringe, Kristina I.

AU - Venkatesh, Sudhakar K

AU - Yamamura, Jin

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra- and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards, and its potential as a research tool is lacking. Conclusion: Members of the International PSC Study Group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards, and future areas of research. (Hepatology 2017;66:1675–1688).

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra- and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards, and its potential as a research tool is lacking. Conclusion: Members of the International PSC Study Group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards, and future areas of research. (Hepatology 2017;66:1675–1688).

UR - http://www.scopus.com/inward/record.url?scp=85032626584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032626584&partnerID=8YFLogxK

U2 - 10.1002/hep.29293

DO - 10.1002/hep.29293

M3 - Review article

C2 - 28555945

AN - SCOPUS:85032626584

VL - 66

SP - 1675

EP - 1688

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -